Polio

Kids 'R' Kids Learning Academies Donates to Annual March of Dimes Fundraiser

Retrieved on: 
Thursday, May 9, 2019
Franklin D. Roosevelt, Polio, Online games, Schools, March of Dimes, Educational institutions, March for Babies, Dime, Club Penguin, Academy

The Kids 'R' Kids Learning Academies Franchise Support Center raises money every year to donate to the March of Dimes, as well as participating in the local March of Dimes March for Babies.

Key Points: 
  • The Kids 'R' Kids Learning Academies Franchise Support Center raises money every year to donate to the March of Dimes, as well as participating in the local March of Dimes March for Babies.
  • This year, Kids 'R' Kids donated a total of $2,761.00 along with a $25,000.00 sponsorship for the March for Babies.
  • The official stage program began at 9:45, where Kids 'R' Kids made their official check donation to March of Dimes.
  • Headquartered in theNorth Atlantasuburb ofDuluth, Georgia, Kids 'R' Kids Learning Academies focus on providing secure, nurturing, and educational environments for children six weeks - 12 years, and their families.

New Story Sharing Initiative Launched By March Of Dimes Will Build Community To Increase Awareness Of Issues Around Pregnancy, Parenthood And Loss This Mother's Day

Retrieved on: 
Tuesday, May 7, 2019
Health, Polio, Articles, Medicine, Women's health, Franklin D. Roosevelt, March of Dimes, Midwifery, Infancy, Preterm birth, Maternal death

March of Dimes is working in communities across the country to reduce the rising rates of premature birth, as well as maternal mortality and morbidity.

Key Points: 
  • March of Dimes is working in communities across the country to reduce the rising rates of premature birth, as well as maternal mortality and morbidity.
  • Our organization supports women before, during and after pregnancy to ensure all mothers and infants are healthy.
  • March of Dimes has the partnerships and community-building connections to convene, help and inspire people to share their stories.
  • Host an Unspoken Conversationwhere friends, families and neighbors can gather to share in personin their community just in time for Mother's Day.

Two New Jersey youth honored for volunteerism at national award ceremony in Washington, D.C.

Retrieved on: 
Monday, May 6, 2019
Polio, Biotechnology, Vaccination, Polio vaccine, Antipolo, Life sciences, Biology, Articles

She also appreciated the importance of vaccines, having watched her father struggle with polio.

Key Points: 
  • She also appreciated the importance of vaccines, having watched her father struggle with polio.
  • "This program helps me to do something meaningful for the country where the majority of my family lives, and for my heritage," said Czarina.
  • She coordinated with health officials in the province of Antipolo Rizal to disseminate information about the vaccinations and obtain parental consent.
  • For B-roll ofNew Jersey's honorees at the 2019 national recognition events, contactPrudential's HaroldBanks at (973) 216-4833 or [email protected].

Myriam Hemberger Receives 2019 March of Dimes Prize For Breakthrough Research On Placental Biology

Retrieved on: 
Monday, April 29, 2019
Polio, March of Dimes, Jonas Salk, Placenta, Awards, Health, Medicine

BALTIMORE, April 29, 2019 /PRNewswire/ --For her pioneering research to explain the biology of the placenta, the crucial organ for pregnancyin humans and most other mammals, Myriam Hemberger, PhD, has been awarded the 2019 March of Dimes and Richard B. Johnston, Jr., MD Prize in Developmental Biology.

Key Points: 
  • BALTIMORE, April 29, 2019 /PRNewswire/ --For her pioneering research to explain the biology of the placenta, the crucial organ for pregnancyin humans and most other mammals, Myriam Hemberger, PhD, has been awarded the 2019 March of Dimes and Richard B. Johnston, Jr., MD Prize in Developmental Biology.
  • Shortly before Dr. Jonas Salk's death in 1995, March of Dimes created this Prize as a tribute to him.
  • Currently, she is also the Theme Lead of the Genes, Development & Health research group at the Alberta Children's Hospital Research Institute (ACHRI).
  • Dr. Hemberger will deliver the 24th annual Prize Lecture today during the 2019 Pediatric Academy Societies annual meeting at the Baltimore Convention Center.

UN Foundation Announces Press Fellowship to Nigeria on Polio Eradication

Retrieved on: 
Thursday, April 25, 2019
Polio, Articles, Health, Medical specialties, Vaccination, Global health, Health campaigns, RTT, Polio eradication, Global Polio Eradication Initiative, Vaccine, World Health Organization

WASHINGTON, April 25, 2019 /PRNewswire-PRWeb/ -- The United Nations Foundation today announced a press fellowship to Nigeria focused on polio eradication during the week of July 22, 2019.

Key Points: 
  • WASHINGTON, April 25, 2019 /PRNewswire-PRWeb/ -- The United Nations Foundation today announced a press fellowship to Nigeria focused on polio eradication during the week of July 22, 2019.
  • They will also hear directly from experts from the Global Polio Eradication Initiative , including UNICEF and the World Health Organization, and local health officials.
  • Due to comprehensive eradication efforts, including an effective vaccine, robust government investment, and dedicated health workers, polio has decreased dramatically worldwide.
  • Conflict and weak health systems threaten progress in the three countries where polio remains endemic Nigeria, Afghanistan, and Pakistan.

Sinovac Announces Positive Results From Phase III Trial Of a Sabin Strain-Based Inactivated Polio Vaccine (sIPV) Published in the Journal of Infectious Disease

Retrieved on: 
Tuesday, April 16, 2019
Health, Biotechnology, Clinical trials, Pharmaceutical, Vaccination, Medical specialties, Medicine, Polio, Vaccines, RTT, Virology, Sinovac Biotech, Polio vaccine, Pneumococcal conjugate vaccine, Vaccination schedule, Immunisation Programme in Hong Kong

Sinovac Biotech Ltd. (SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the positive results from the Companys Phase III clinical study of a Sabin strain-based inactivated polio vaccine (sIPV) developed by Sinovac were published in the Journal of Infectious Disease.

Key Points: 
  • Sinovac Biotech Ltd. (SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the positive results from the Companys Phase III clinical study of a Sabin strain-based inactivated polio vaccine (sIPV) developed by Sinovac were published in the Journal of Infectious Disease.
  • In comparison to oral polio vaccine (OPV), inactivated polio vaccine (IPV) contains no live virus and thus carries no risk of vaccine-derived poliovirus (VDPV) emergence or vaccine-associated paralytic polio (VAPP).
  • The EV71 vaccine, an innovative vaccine developed by Sinovac against hand foot and mouth disease caused by EV71, was commercialized in China in 2016.
  • The Company is developing a number of new products including a Sabin-strain inactivated polio vaccine, pneumococcal polysaccharides vaccine, pneumococcal conjugate vaccine and varicella vaccine.